Medicare Enrolled

Dr. Marshall Bedder, M.D.

Pain Medicine · Augusta, GA
Speaking/Promotional
1120 15TH ST, Augusta, GA 30912
7067213813
In practice since 2005 (20 years)
NPI: 1013906833 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bedder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bedder? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bedder

Dr. Marshall Bedder is a pain medicine specialist in Augusta, GA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Bedder received a total of $193,605 from 42 pharmaceutical and/or device companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bedder is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $193,605 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$193,605
Total received (2018-2024)
Avg $27,658/year across 7 years
Top 0% in GA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161,191 (83.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,496 (12.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,699 (4.0%)
Other
Charitable contributions, space rental, and other categories
$1,220 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,735
2023
$1,380
2022
$13,502
2021
$27,590
2020
$35,016
2019
$47,469
2018
$53,912

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Kedplasma LLC
$13,025
Boston Scientific Corporation
$839
Nevro Corp.
$398
Abbott Laboratories
$161
Spinal Simplicity, LLC
$110
Medtronic, Inc.
$83
Saluda Medical Americas, Inc.
$83
Vertos Medical, Inc.
$35
Top 3 companies account for 96.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$84,188
BOSTON SCIENTIFIC CORPORATION
$78,583
Kedplasma LLC
$13,025
SPR Therapeutics, Inc
$9,198
Vertiflex, Inc.
$1,627
INTERNATIONAL REHABILITATIVE SCIENCES, INC
$1,534
Nevro Corp.
$1,326
Medtronic, Inc.
$671
Saluda Medical Americas, Inc.
$516
Nuvectra Corporation
$416
Stimwave Technologies Incorporated
$346
PAINTEQ LLC
$237
BioDelivery Sciences International, Inc.
$213
Abbott Laboratories
$161
Medtronic USA, Inc.
$140
Collegium Pharmaceutical, Inc.
$130
Averitas Pharma Inc.
$120
Supernus Pharmaceuticals, Inc.
$119
Spinal Simplicity, LLC
$110
Curonix LLC
$108
Amgen Inc.
$101
Daiichi Sankyo Inc.
$94
SI-BONE, Inc.
$92
Vertos Medical, Inc.
$90
PFIZER INC.
$61
Bioventus LLC
$59
Arbor Pharmaceuticals, Inc.
$34
US WorldMeds, LLC
$34
SCILEX PHARMACEUTICALS INC.
$33
GRT US Holding, Inc.
$33
ARBOR PHARMACEUTICALS, INC.
$32
Electronic Waveform Lab, Inc.
$24
Indivior Inc.
$20
Assertio Therapeutics, Inc.
$18
Orthogenrx Inc.
$17
MY01 Inc.
$17
ASSERTIO THERAPEUTICS, Inc.
$16
FIDIA PHARMA USA INC.
$14
Sentynl Therapeutics, Inc.
$12
Novartis Pharmaceuticals Corporation
$12
Pernix Therapeutics Holdings, Inc.
$12
Scilex Pharmaceuticals Inc.
$11
Top 3 companies account for 90.8% of all-time payments
Associated products mentioned in payments ›
Aimovig · Algovita · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Cambia · Durolane · ENTRADA · ETERNA · Evoke · Evoke SCS · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GenVisc 850 · General - Pain Management · Gralise · HA MINUTEMAN G3-R · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON EXPRESS II KYPHOPAK TRAY · LYRICA · Levorphanol Tartrate · Lucemyra/Lofexidine · MY01 Continuous Compartmental Pressure Monitor · Morphabond ER · OXTELLAR XR · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRECISION · QUTENZA · Qutenza · RS 4i Plus Sequential Stimulator · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SUBLOCADE · SUPERION · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · Superion Indirect Decompression System · THERAPIES · TROKENDI XR · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for pain medicine in GA.

Looking for a pain medicine specialist in Augusta?
Compare pain medicines in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
17
Per 100K population
8.3
County median income
$53,197
Nearest hospital
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bedder is a pain medicine specialist, with speaking/promotional industry engagement in the top 0% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Bedder receive payments from pharmaceutical companies?
Yes. Dr. Bedder received a total of $193,605 from 42 companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Bedder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →